Abstract
Implanted mechanical circulatory support devices are an alternative treatment for end-stage heart failure. These mechanical devices can be used as a bridge to heart transplant, myocardial recovery, or as destination therapy. Left ventricular assisted devices improves peripheral blood circulation, decreases pulmonary hypertension, reduces organ dysfunction and improves the quality of life in heart failure patients. To date, the design features of modern implantable devices make it possible to increase the reliability of these systems, minimize the trauma of erythrocytes, provide more stable coagulation, and also reduce the risk of pump thrombosis and bleeding. In this report, we present the first experience of using the left ventricular assist device – HeartMate 3 for patient with dilated cardiomyopathy and end-stage heart failure.
References
- Itkin G.P Ventricle assist device: past, present and future nonpulsative pumps. Russian Journal of Transplantology and Artificial Organs. 2009; 11 (3): 81–7 (in Russ.). DOI: 10.15825/1995-1191-2009-3-81-87
- Kirklin J.K., Naftel D.C., Pagani F.D., Kormos R.L., Stevenson L.W., Blume E.D. et al. Seenth INTERMACS annual report: 15,000 patients and counting. J. Heart Lung Transplant. 2015; 34: 1495–504. DOI: 10.1016/j.healun.2015.10.003
- Slaughter M.S., Rogers J.G., Milano C.A., Russel S.D., Conte J.V., Feldman D. et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 2009; 361 (23): 2241–51. DOI: 10.1056/NEJMoa0909938
- Shah S.R., Alweis R. Acute coronary artery dissection: a review of the literature and current evidence. Cardiol. Rev. 2018; 26 (5): 274–6. DOI: 10.1097/CRD. 0000000000000186
- Shah S.R., Uddin M.F., Lateef N., Dharani A.M., Shahnawaz W., Kazi A.N. et al. Evolocumab to reduce cardiovascular events: results of the (FOURIER) multinational trial. J. Community Hosp. Intern. Med. Perspect. 2017; 7 (3): 199–200. DOI: 10.1080/20009666.2017.1340732. eCollection 2017.
- Shah S.R., Alweis R., Shah S.A., Arshad M.H., Manji A.A., Arfeen A.A. et al. Effects of colchicine on pericardial diseases: a review of the literature and current evidence. J. Community Hosp. Intern. Med. Perspect. 2016; 6 (3): 31957. DOI: 10.3402/jchimp.v6.31957. eCollection 2016.
- Monkowski D., Axelrod P., Fekete T., Hollander T., Fu-rukawa S., Samuel R. Infections associated with ventri-cular assist devices: epidemiology and effect on prognosis after transplantation. Transpl. Infect. Dis. 2007; 9 (2): 114–20. DOI: 10.1111/j.1399-3062.2006.00185
- Asleh R., Schettle S., Khan F., Kushwaha S. Left ventricular assist devices as destination therapy in stage D heart failure. J. Geriatr. Cardiol. 2019; 16 (8): 592–600. DOI: 10.11909/j.issn.1671-5411.2019.08.009
- Stevenson L.W., Pagani F.D., Young J.B., Jessup M., Miler L., Kormos R.L. et al. INTERMACS profiles of advanced heart failure: the current picture. J. Heart Lung Transplant. 2009; 28 (6): 535–41. DOI: 10.1016/j.healun.2009.02.015
- Goldstein D.J., Oz M.C., Rose E.A. Implantable left ventricular assist devices. N. Engl. J. Med. 1998; 339 (21): 1522–33. DOI: 10.1056/NEJM199811193392107
- Heatley G., Sood P., Goldstein D. et al. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circula-tory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. J. Heart Lung Transplant. 2016; 35: 528–36. DOI: 10.1016/j.healun.2016.01.021
About the authors
- Leo A. Bockeria, Academician of RAS and RAMS, President; ORCID
- Konstantin V. Shatalov, Dr. Med. Sci., Professor, Head of Department; ORCID
- Zamik F. Fatulaev, Cand. Med. Sci., Leading Researcher; ORCID
- Merab K. Sanakoev, Cand. Med. Sci., Researcher; ORCID
- Maksim V. Makhalin, Cand. Med. Sci., Cardiovascular Surgeon; ORCID
- Marina Yu. Mironenko, Cand. Med. Sci., Head of Department; ORCID
- Vitaliy B. Andreev, Cardiologist; ORCID
